Literature DB >> 26345803

Correlation between the decrease of cholesterol efflux from macrophages in patients with type II diabetes mellitus and down-regulated CYP7A1 expression.

L D Bao1, C Q Li2, R Peng1, X H Ren1, R L Ma1, Y Wang1, H J Lv3.   

Abstract

The purpose of this study was to examine the changes of cellular cholesterol efflux from macrophages in patients with type II diabetes mellitus (DM), and to determine the expression of CYP7A1, ABCG5, and LXRβ therein. We recruited 30 patients with type II DM (including 15 patients complicated with coronary heart disease and 15 patients with DM only) and 15 normal controls for this study. Peripheral blood monocytes were isolated for macrophage culture. The mRNA and protein expression levels of CYP7A1, ABCG5, and LXRβ were determined using real-time polymerase chain reaction and western blot. The macrophage cholesterol efflux rate was determined with 10% autoserum and standard serum as receptors. We determined that the expression levels of macrophage CYP7A1 mRNA and protein in the type II DM group were significantly lower than those in the control group, but no differences were found in the ABCG5 and LXRβ expression levels between the groups. The macrophage cholesterol efflux rate in the patients with type II DM was also significantly decreased compared with that of the normal control subjects (P < 0.01). Furthermore, CYP7A1 mRNA expression and macrophage cholesterol efflux rate were significantly positively correlated. In summary, this study demonstrated that the macrophage cholesterol efflux in patients with type II DM was significantly reduced, and that this reduction was associated with the down-regulation of CYP7A1 expression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26345803     DOI: 10.4238/2015.July.31.20

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  5 in total

Review 1.  The complex interplay among hepatocytes and immune cells at the crossroad between inflammation and cholesterol metabolism in hyperglycemia.

Authors:  Maurizio Bifulco; Simona Pisanti; Elena Ciaglia
Journal:  Endocrine       Date:  2017-02-08       Impact factor: 3.633

Review 2.  Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.

Authors:  Rai Ajit K Srivastava
Journal:  Mol Cell Biochem       Date:  2017-08-21       Impact factor: 3.396

3.  Unconjugated p-cresol activates macrophage macropinocytosis leading to increased LDL uptake.

Authors:  Lee D Chaves; Sham Abyad; Amanda M Honan; Mark A Bryniarski; Daniel I McSkimming; Corrine M Stahura; Steven C Wells; Donna M Ruszaj; Marilyn E Morris; Richard J Quigg; Rabi Yacoub
Journal:  JCI Insight       Date:  2021-06-08

Review 4.  High Density Lipoproteins and Diabetes.

Authors:  Blake J Cochran; Kwok-Leung Ong; Bikash Manandhar; Kerry-Anne Rye
Journal:  Cells       Date:  2021-04-09       Impact factor: 6.600

5.  Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis.

Authors:  Neelam Srivastava; Angelo B Cefalu; Maurizio Averna; Rai A K Srivastava
Journal:  Front Physiol       Date:  2018-09-11       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.